在与炎症相关的疾病和其抑制剂中,对赫索金酶2的研究进展

Jinxia Chen1, Guirong Li1, Dejuan Sun1

  • 1Wuya College of Innovation, Key Laboratory of Structure-Based Drug Design & Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang, 110016, China.

概括

基酶2 (HK2) 通过调解糖解和细胞因子释放来驱动炎症. 针对HK2为许多炎症性疾病提供了一个有前途的治疗策略.